Press Releases Items Per Page 102550 Year None202020192018201720162015201420132012201120102007 12.18.20 Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index 12.11.20 Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares 12.09.20 Syndax Announces Pricing of Public Offering of Common Stock 12.07.20 Syndax Announces Proposed Public Offering of Common Stock 12.06.20 Syndax Pharmaceuticals Announces Additional Positive Data from Phase 1 Trial of Axatilimab in Patients with cGVHD 11.30.20 Syndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD Experts 11.11.20 Syndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference 11.04.20 Syndax Pharmaceuticals to Present Updated Data from Phase 1 Trial of Axatilimab in cGVHD During Oral Session at the 62nd ASH Annual Meeting 11.02.20 Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update 10.26.20 Syndax to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 2, 2020 09.02.20 Syndax Announces Participation at Three Upcoming Investor Conferences 08.06.20 Syndax Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
12.11.20 Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
12.06.20 Syndax Pharmaceuticals Announces Additional Positive Data from Phase 1 Trial of Axatilimab in Patients with cGVHD
11.30.20 Syndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD Experts
11.04.20 Syndax Pharmaceuticals to Present Updated Data from Phase 1 Trial of Axatilimab in cGVHD During Oral Session at the 62nd ASH Annual Meeting
11.02.20 Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update
10.26.20 Syndax to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 2, 2020
08.06.20 Syndax Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
